Alvotech (ALVO) Long-Term Investments (2020 - 2024)
Alvotech's (ALVO) quarterly Long-Term Investments came in at $18.5 million in Q1 2024, little changed quarter-over-quarter from $18.5 million in Q4 2023.
Analysis
Alvotech (ALVO) Long-Term Investments (2020 - 2024) Analysis & Trends
Alvotech (ALVO) has reported Long-Term Investments for 5 consecutive years, with $18.5 million the latest figure, recorded in Q1 2024.
- For the quarter ending Q1 2024, Long-Term Investments changed N/A year-over-year to $18.5 million; the trailing twelve-month figure through Mar 2024 stood at $18.5 million (changed N/A YoY), and the FY2023 full-year result was $18.5 million, down 61.92% from the prior year.
- Long-Term Investments held at $18.5 million in Q1 2024 per ALVO's latest filing, from $18.5 million in the prior quarter.
- Across five years, Long-Term Investments topped out at $56.7 million in Q4 2020 and bottomed at $18.5 million in Q4 2023.
- Historically, Long-Term Investments has averaged $41.8 million across 5 years, with a median of $48.6 million in 2022.
- The sharpest annual moves came in 2021 and 2023: Long-Term Investments retreated 2.42% in 2021, then plunged 61.92% in 2023.
- Over 5 years, Long-Term Investments stood at $56.7 million in 2020, then fell by 2.42% to $55.3 million in 2021, then retreated by 12.18% to $48.6 million in 2022, then sank by 61.92% to $18.5 million in 2023, then changed by 0.0% to $18.5 million in 2024.
- According to Business Quant data, Long-Term Investments over the past three periods registered $18.5 million, $18.5 million, and $43.6 million for Q1 2024, Q4 2023, and Q2 2023 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | - |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 848.23 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | - |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 16.30 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | 12.05 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | 18.49 Mn |
| Dec 31, 2023 | 18.49 Mn |
| Jun 30, 2023 | 43.61 Mn |
| Dec 31, 2022 | 48.57 Mn |
| Jun 30, 2022 | 51.33 Mn |
| Dec 31, 2021 | 55.31 Mn |
| Dec 31, 2020 | 56.68 Mn |